Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality (GESEMM)

February 6, 2024 updated by: Gianluca Costa, Campus Bio-Medico University

Mortality and Morbidity in Emergency Gastrointestinal Surgery: Comparison of Different Incidence of Interventions According to the ICD-9-CM Classification in Relation to the Age Groups

Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality

Study Overview

Detailed Description

Background: Gastrointestinal emergencies (GE) are frequently encountered in the emergency department (ED), and patients can present with wide-ranging symptoms. Symptoms that suggest an underlying GE can include: abdominal pain; nausea; vomiting; diarrhoea; melaena; haematemesis; constipation; jaundice; and abdominal distension. Abdominal pain is a common ED presentation and can be the cause of a wide variety of GE. The acute abdomen (AB) is a term given to sudden severe pain in the abdomen requiring fast diagnosis and treatment usually requiring emergency surgical procedures. Causes of AB may include: appendicitis; pancreatitis; peptic ulcer disease (PUD); gall bladder pathology; intestinal ischemia; diverticulitis; intestinal obstruction; and ruptured ectopic pregnancy. Emergency gastrointestinal surgery (EGS) is burdened by significant mortality and morbidity rates because it is performed with little to no advance planning or preparation, on patients who are in dire straits. Scott JW et al report that there are more than 3 million patients admitted to US hospitals each year for EGS diagnoses, more than the sum of all new cancer diagnoses. (Scotte JW) In addition to the complexity of the urgent surgical patient (often suffering from multiple co-morbidities), there is the unpredictability and the severity of the event. Frequently, it is necessary rapid decision-making that allows a correct diagnosis and an adequate and timely treatment. (See Ref.) Moreover, another study by Havens JM et al reported that patients undergoing EGS operation are up to 8 times more likely to die postoperatively than are patients undergoing the same procedures electively. Furthermore, the increase in average life will lead more and more people over 65 to face surgical pathologies in an emergency setting, and in the elderly EGS is characterized by greater morbidity and mortality as well as by a global worsening of the residual quality of life (QoL). The explanation for the high percentage of acute complications could be found in the inevitable reduction of the functional reserve related to age. An example is the reduction of the body's immune defenses in the humoral response of B cells, in the cell-mediated immune function and macrophage activity which explains the susceptibility to infectious complications, facilitated by the altered integrity of the skin barrier and mucous membranes too. Is in this setting that tools capable to help the surgeon in the decision-making process in order to reduce mortality and morbidity linked to the EGS could become very useful. To do this, it is necessary to study the greatest number of risk factors associated with EGS, considering all age groups and all types of diseases.

AIM: To analyze the clinicopathological findings, management strategies, and short-term outcomes of gastrointestinal emergency procedures; to evaluate the prognostic role of existing risk-scores; to define the most suitable scoring system or gastro-intestinal surgical emergency; to identify any specific parameters that may be used as variables for a new scoring system, peri-operative variables predicting adverse results and any critical issues in the management of these patients.

STUDY DESIGN: both retrospective and prospective cohort, multicenter, observational, no profit clinical study. All the study participants will collect data on > 18 y. o. patients underwent general emergency surgery during an 18 month period, guaranteeing whole completeness of the picked data > 95%. This study was approved by the Health Sciences Research Ethics Board of the University Campus Biomedio of Rome

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Lazio
      • Rome, Lazio, Italy, 00136
        • Recruiting
        • Università Campus Biomedico
        • Contact:
        • Sub-Investigator:
          • Gabriella Teresa Capolupo, MD, PhD
        • Sub-Investigator:
          • Filippo Carannante, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Multicenter italian national survey cohort study

Description

Inclusion Criteria:

  • 18 y.o. completed at the day of surgery
  • Emergency gastrointestinal surgery considered as not-scheduled procedure

Exclusion Criteria:

  • Age under 18 y.o. at the day of surgery
  • Lack of informed consent
  • Patients already hospitalized and scheduled for the same procedure
  • Participation in another trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day morbidity rate
Time Frame: 18 months
Morbidity defined by mean of the Clavien's Classification scoring system
18 months
30-day mortality rate
Time Frame: 18 months
any cause of mortality related to surgical procedure
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Simplified Acute Physiology Score-II (SAPS-II)
Time Frame: 18 months
Calculation and evaluation of its predictive value for mortality
18 months
American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) surgical risk calculator
Time Frame: 18 months
Calculation and evaluation of its predictive value for post-operative complications
18 months
Calculation of Charlson Age-Comorbidity Index (CACI)
Time Frame: 8 months
Calculation and evaluation of its predictive value for morbidity and mortality
8 months
5-item Frailty Index
Time Frame: 18 months
Frailty stratification in participants
18 months
Total number of subjects underwent emergency surgery
Time Frame: 18 months
Number of patients submitted to surgery
18 months
Emergency Surgical Frailty Index (EmFSI)
Time Frame: 18 months
Frailty stratification in participants
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

August 30, 2023

Study Completion (Estimated)

August 31, 2025

Study Registration Dates

First Submitted

January 18, 2022

First Submitted That Met QC Criteria

February 1, 2022

First Posted (Actual)

February 7, 2022

Study Record Updates

Last Update Posted (Estimated)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Cancer

Subscribe